Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Angioedema Treatment Market Valued at Present and by 2029?

In recent times, the market size for angioedema treatment has witnessed swift growth. The prediction is that the market will expand from a value of $2.72 billion in 2024 to $3.13 billion in 2025, showing a compound annual growth rate (CAGR) of 15.0%. The historical growth was fueled by multiple factors including enhanced government support, increased rates of diagnosis, a greater number of autoimmune disorders, an increase in clinical trials, and expansion in healthcare infrastructure.

Expectations are high for a swift escalation in the angioedema treatment market size in the imminent years. The market is projected to reach a value of $5.4 billion by 2029, with a compound annual growth rate (CAGR) of 14.6%. The forecasted expansion in this period is correlated with factors such as an upsurge in healthcare spending, heightened awareness of allergies, surge in chronic disease occurrence, increased incidence and prevalence of angioedema, and an intensified focus on personalized medicine. During the forecast period, several significant trends are anticipated, including progress in diagnostic technologies, incorporation of machine learning, investments funnelled towards research and development, embracing of telemedicine, and obtaining regulatory approvals for faster market access.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24460&type=smp

#What Drivers Are Influencing Growth In The Angioedema Treatment Market?

The angioedema treatment market is anticipated to expand due to a surge in the instances of rare illnesses. Such diseases, which affect only a tiny fraction of the population, usually have limited therapeutic options and can significantly impact health. Thanks to advancements in genetic testing and diagnostic techniques, the ability to identify and correctly diagnose previously unrecognized conditions has increased — leading to increased reported prevalence of these conditions. In treating uncommon disorders like hereditary angioedema, angioedema therapy offers specialized treatments that prevent and control severe swelling episodes, thereby improving patient outcomes. As an example, in November 2024, the US federal agency, Food and Drug Administration, reported that over 7,000 rare diseases affected more than 30 million people in the United States. Accordingly, the escalating incidence of rare diseases is fueling the growth of the angioedema treatment market.

What Are The Main Segments Identified In The Angioedema Treatment Market Research?

The angioedema treatment market covered in this report is segmented –

1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema

2) By Route Of Administration: Injection, Oral

3) By End Use: Hospitals, Clinics, Research Organizations

1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies

2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors

3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management

4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics

What Are The Leading Trends And Opportunities In The Angioedema Treatment Sector?

Leading corporations in the angioedema treatment sector are striving to innovate new solutions like subcutaneous injections, aiming to provide fast and easy relief for patients enduring acute hereditary angioedema (HAE) attacks. This injection method allows for the steady and slow absorption of medication into the blood through the fatty tissue under the skin. For example, in April 2025, the Australian biotech firm, CSL Limited, introduced a unique, fully human monoclonal antibody treatment for acute attacks prevention in HAE patients. The new drug, ANDEMBRY (garadacimab), is the pioneer pre-filled pen for once-monthly subcutaneous usage, providing a convenient option for long-term prevention. The drug operates by inhibiting Factor XII (Factor XIIa), a principle precursor in the angioedema sequence, thus marking a significant improvement in HAE management through providing efficient patient-centric disease control.

Which Companies Play A Key Role In The Development Of The Angioedema Treatment Market?

Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/angioedema-treatment-global-market-report

What Are The Key Regional Developments Shaping The Angioedema Treatment Market?

North America was the largest region in the angioedema treatment market in 2024. The regions covered in the angioedema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24460&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model